Creative Planning Repligen Corp Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Repligen Corp stock. As of the latest transaction made, Creative Planning holds 5,123 shares of RGEN stock, worth $736,738. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,123

Previous 3,864 32.58%

Holding current value

$736,738

Previous $487,000 56.47%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$119.79 - $167.35 $150,815 - $210,693	1,259 Added 32.58%	5,123 $762,000
Q2 2024 Aug 15, 2024	SELL	$120.0 - $182.95 $1,440 - $2,195	-12 Reduced 0.31%	3,864 $487,000
Q1 2024 May 10, 2024	BUY	$170.78 - $208.42 $2,903 - $3,543	17 Added 0.44%	3,876 $712,000
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $44,297 - $71,915	388 Added 11.18%	3,859 $693,000
Q3 2023 Nov 16, 2023	SELL	$138.78 - $176.51 $48,156 - $61,248	-347 Reduced 9.09%	3,471 $551,000
Q2 2023 Jul 21, 2023	BUY	$138.42 - $180.31 $103,122 - $134,330	745 Added 24.24%	3,818 $540,000
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $71,730 - $92,116	465 Added 17.83%	3,073 $517,000
Q4 2022 Feb 10, 2023	BUY	$162.42 - $220.56 $36,544 - $49,626	225 Added 9.44%	2,608 $441,000
Q3 2022 Nov 03, 2022	BUY	$160.42 - $256.21 $43,955 - $70,201	274 Added 12.99%	2,383 $446,000
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $20,679 - $27,638	147 Added 7.49%	2,109 $343,000
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $3,062 - $4,901	-19 Reduced 0.96%	1,962 $369,000
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $5,942 - $7,307	-24 Reduced 1.2%	1,981 $525,000
Q3 2021 Nov 10, 2021	SELL	$194.77 - $324.21 $91,931 - $153,027	-472 Reduced 19.06%	2,005 $579,000
Q2 2021 Aug 04, 2021	SELL	$165.87 - $220.95 $1.66 Million - $2.21 Million	-9,982 Reduced 80.12%	2,477 $494,000
Q1 2021 Apr 30, 2021	BUY	$180.37 - $226.26 $134,375 - $168,563	745 Added 6.36%	12,459 $2.42 Million
Q4 2020 Jan 29, 2021	BUY	$148.08 - $206.57 $69,893 - $97,501	472 Added 4.2%	11,714 $2.25 Million
Q3 2020 Nov 05, 2020	SELL	$122.51 - $158.27 $612 - $791	-5 Reduced 0.04%	11,242 $1.66 Million
Q2 2020 Jul 23, 2020	BUY	$94.33 - $140.48 $44,995 - $67,008	477 Added 4.43%	11,247 $1.39 Million
Q1 2020 May 05, 2020	SELL	$84.96 - $109.14 $451,647 - $580,188	-5,316 Reduced 33.05%	10,770 $1.04 Million
Q4 2019 Jan 30, 2020	BUY	$73.84 - $93.08 $5,981 - $7,539	81 Added 0.51%	16,086 $1.49 Million
Q3 2019 Nov 01, 2019	SELL	$76.65 - $95.51 $53,655 - $66,857	-700 Reduced 4.19%	16,005 $1.23 Million
Q2 2019 Jul 26, 2019	BUY	$54.2 - $85.95 $905,411 - $1.44 Million	16,705 New	16,705 $1.44 Million

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.98B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Repligen Corp Transaction History